• Abruzzo, L.V., Rosales, C.M., Medeiros, L.J., Vega, F., Luthra, R., Manning, J.T., Keating, M.J. & Jones, D. (2002) Epstein–Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms. American Journal of Surgical Pathology, 26, 630636.
  • Asano, N., Yamamoto, K., Tamarau, J., Oyama, T., Ishida, F., Ohshima, K., Yoshino, T., Nakamura, N., Mori, S., Yoshie, O., Shimoyama, Y., Morishima, Y., Kinoshita, T. & Nakamura, S. (2009) Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood, 113, 26292636.
  • Biggar, R.J., Jaffe, E.S., Goedert, J.J., Chaturvedi, A., Pfeiffer, R. & Engels, E.A. (2006) Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood, 108, 37863791.
  • Cheson, B.D., Horning, S.J., Coiffier, B., Shipp, M.A., Fisher, R.I., Connors, J.M., Lister, T.A., Vose, J., Grillo-López, A., Hagenbeek, A., Cabanillas, F., Klippensten, D., Hiddemann, W., Castellino, R., Harris, N.L., Armitage, J.O., Carter, W., Hoppe, R. & Canellos, G.P. (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. Journal of Clinical Oncology, 17, 1244.
  • Eghbali, H., Raemaekers, J. & Carde, P. (2005) The EORTC strategy in the treatment of Hodgkin's lymphoma. European Journal of Haematology. Supplement, 13, 540.
  • Garnier, J.L., Lebranchu, Y., Dantal, J., Bedrossian, J., Cahen, R., Assouline, D., Jaccard, A., Fetissoff, F., Moreau, A., Martin, X., Delsol, G., Berger, F. & Touraine, J.L. (1996) Hodgkin disease after transplantation. Transplantation, 61, 7176.
  • Glaser, S.L., Lin, R.J., Stewart, S.L., Ambinder, R.F., Jarrett, R.F., Brousset, P., Pallesen, G., Gulley, M.L., Khan, G., O'Grady, J., Hummel, M., Preciado, M.V., Knecht, H., Chan, J.K. & Claviez, A. (1997) Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. International Journal of Cancer, 70, 375382.
  • Greaves, W.O., Bueso-Ramos, C. & Fayad, L. (2011) Classical Hodgkin's lymphoma associated with Langerhans cell histiocytosis: multiagent chemotherapy resulted in histologic resolution of both the classical Hodgkin's lymphoma and Langerhans cell proliferation components. Journal of Clinical Oncology, 29, e76e78.
  • Hasenclever, D. & Diehl, V. (1998) A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. New England Journal of Medicine, 339:15061514.
  • Küppers, R. (2009) The biology of Hodgkin's lymphoma. Nature Review Cancer, 9, 1527.
  • Mariette, X., Cazals-Hatem, D., Warszawki, J., Liote, F., Balandraud, N. & Sibilia, J. (2002) Investigators of the Club Rhumatismes et Inflammation. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood, 99, 39093915.
  • Sanchez, S., Holmes, H., Katabi, N., Newman, J., Domiatti-Saad, R., Stone, M. & Netto, G. (2006) Composite lymphocyte-rich Hodgkin lymphoma and peripheral T-cell lymphoma associated with Epstein–Barr virus: a case report and review of the literature. Archives of Pathology & Laboratory Medicine, 130, 107112.
  • Shankaran, V., Ikeda, H., Bruce, A.T., White, J.M., Swanson, P.E., Old, L.J. & Schreiber, R.D. (2001) IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature, 410, 11071111.
  • Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. International Agency for Research on Cancer, Lyon, France.
  • Willenbrock, K., Bräuninger, A. & Hansmann, M.-L. (2007) Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein–Barr virus-infected cells in early cases. British Journal of Haematology, 138, 733739.